Home Business NewsBusiness GSK pulls out of $20bn race for Pfizer healthcare business

GSK pulls out of $20bn race for Pfizer healthcare business

by LLB Reporter
23rd Mar 18 11:17 am

Shares in British drugmaker jumped 4 per cent

British drugmaker GlaxoSmithKline said today that it has withdrawn from the race to buy Pfizer’s consumer healthcare unit, just a day after its main rival Reckitt Benckiser quit from bidding.

GSK shares jumped 4 per cent in early trading.

Pfizer has been hoping to fetch as much as $20bn for its unit, which includes brands such as Advil, Centrum multivitamins and Chapstick lip balm, according to the sources.

“While we will continue to review opportunities that may accelerate our strategy, they must meet our criteria for returns and not compromise our priorities for capital allocation,” Chief Executive Emma Walmsley said.

 

Leave a Commment

CLOSE AD

Sign up to our daily news alerts

[ms-form id=1]